|
Combination of innovative strength and leading technological expertise
|
|
Manjushree Naik
April 09 , 2026
|
|
|
Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025.
According to Yilia Yan of Evonik Specialty Chemicals, the common motivation of the approximately 31,000 employees at the company is to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives in all markets.
Last month, the company launched Sphinox Vively, an advanced designer sphingolipid engineered to elevate skin vitality through a unique synergy of biotechnology, barrier science, and high performance efficacy, at PCHi 2026 in Hangzhou, underlining China’s position as one of the world’s most dynamic markets for multidimensional anti aging innovation.
As a new generation multifunctional bioactive sphingolipid, Sphinox Vively delivers retinol like rejuvenation with significantly improved tolerance. It stimulates elastin and hyaluronic acid production at a level comparable to unencapsulated retinol, yet without its typical irritation or barrier disruption. The ingredient also strengthens the skin barrier by increasing Ceramide AP and EOP levels, supporting faster recovery after external stress. By reducing IL 1a release, Sphinox Vively helps maintain a calmer, more resilient skin environment, with visible improvements validated by robust scientific data.
Yan continues, “We have an exciting new product launch in China. This is one of our core competencies for Evonik. It created a new dimension of biotechnological connectivity for us. So compared to conventional ceramides, this has much better penetration, higher efficacy, while still remaining very mild and soothing on the skin and has impressive very good results. So it is a good potential new ingredient and we are ready with the global supply chain and hopefully customers, especially, Chinese customers getting ready for some skin health solutions.”
Yan points out that this is a reflection and accumulation of Evonik’s scientific research on ceramides overall for the past 30 years. So we have created a biological and technological platform to create human skin identical ceramides so that ceramides become recognisable by skin cells. “And, then we also created designer sphingolipid concept so that we are combining unique and novel structures to already change the boundaries of biological activity for ceramides and sphingolipids overall. This is enabling us to create new products as such and new biological efficacies. What we see today overall it is not only taking care of your skin as active ingredients it is enabling skin to enhance itself bringing in more resilience and making it more stronger.”
In regard to sustainability, Yin states that it is biotechnology to begin with. “It is from a very special species of yeast strain that we isolated from so has very vegetable origin and biotechnology based platform.”
Delving deeper into what the company is about, Yan says that Evonik is one of the leading suppliers of personal care. “Apart from actives innovation we also lead the innovation for functional ingredients so sustainable naturally derived emulsifiers, skin conditioning agents as well as biosurfactants - one of the core competencies. We collaborate with the Chinese market, the leading customers here to create solutions, which are milder and more effective.”
As for India presence, Yan observes, Our strategic consideration for India is very crucial one. We have years of strategic department in the region for Evonik’s direct support and strengthening of the company’s presence. One of the recent example is we opened a skin institute in Mumbai. We are expanding our testing capabilities and efficacies evaluation capabilities for our functional and active ingredients to strengthen the capabilities within India.”
She goes on to explain about the company’s presence across the world. “We have presence of our innovations team in different regions. One of the key advantages of that is we have localised the technical solutions for the market they are in so generating more market relevant guideline formulations to help better introduce the product to the final formulas to the local customers.”
Yan adds, “These regional and local innovation capabilities play a very critical role in that the presence of our regional teams provides us with first hand information and feedbacks regarding the local needs. What are the consumer trends in that particular market and how can we better utilise our products and solutions.”
She trails off, “We want to continue with the efforts generating more original relevant data and dossier in regard to regional customers and Indian customers and better serve their needs.”
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|